Villous atrophy induced by mycophenolate mofetil in renal-transplant patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Transplant International

• Publication date

  2004-08-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S00147-004-0745-0PMID 15322747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea

  2003cited by this paper
• Celiac sprue.

  2002cited by this paper
• Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat.

  2001cited by this paper
• Adverse Gastrointestinal Effects of Mycophenolate Mofetil

  2001cited by this paper
• Mycophenolate mofetil may induce apoptosis in duodenal villi.

  2000cited by this paper
• Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain.

  1999cited by this paper
• Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.

  1999cited by this paper
• Mycophenolate mofetil-induced villous atrophy.

  1998cited by this paper
• Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)

  1996cited by this paper
• A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

  1996cited by this paper
• Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

  1995cited by this paper

• Population pharmacokinetic modeling of missed mycophenolate mofetil doses: Impact on exposure and exploration of mitigation strategies

  2025cites this paper
• Long-term Prognosis of Nonceliac Enteropathies and a Score to Identify Patients With Poor Outcomes: A 30-year Multicenter Longitudinal Study

  2025cites this paper
• Diagnostic Challenges in Enteropathies: A Histopathological Review

  2025cites this paper
• The Importance of the FUT2 rs602662 Polymorphism in the Risk of Cardiovascular Complications in Patients after Kidney Transplantation

  2024cites this paper
• Celiac-Like Duodenopathy Associated With Enteric-Coated Mycophenolate Sodium Immunosuppression in Renal Transplant Recipients: Report of 4 Cases.

  2023cites this paper
• Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges

  2023cites this paper
• Olmesartan Associated Enteropathy, an easily overlooked etiology of bowel disturbance: report of three cases

  2022cites this paper
• Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus

  2022cites this paper
• Post Liver Transplantation Diarrhea: Etiology, Evaluation and Treatment

  2021cites this paper
• Norovirus Infections in Kidney Transplant Recipients

  2021cites this paper
• Mycophenolate-Associated Sprue-Like Intestinal Disease Evolving into Collagenous Sprue

  2021cites this paper
• Small and Large Intestine (I): Malabsorption of Nutrients

  2021cites this paper
• Review article: drug‐induced small bowel injury

  2021cites this paper
• Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study

  2020cites this paper
• STUDY OF THE CLINICAL AND MOLECULAR PHENOTYPE AND NATURAL HISTORY OF ENTEROPATHIES WITH VILLOUS ATROPHY OF UNKNOWN ORIGIN AND THERAPEUTIC POTENTIAL OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS

  2019cites this paper
• Mycophenolates: The latest modern and potent immunosuppressive drugs in adult kidney transplantation: what we should know about them?

  2019cites this paper
• Overview in the clinical management of patients with seronegative villous atrophy

  2019cites this paper
• Vitamin B12 status in kidney transplant recipients: association with dietary intake, body adiposity and immunosuppression

  2019cites this paper
• Effects of Drugs and Excipients on Hydration Status

  2019cites this paper
• Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients

  2018cites this paper
• Inflammatory and infectious manifestations of immunodeficiency in the gastrointestinal tract

  2018cites this paper
• Olmesartan-induced enteropathy

  2018cites this paper
• Title : Rare Case of Olmesartan Induced Enteropathy

  2017cites this paper
• Clinical-Pathological Conference Series from the Medical University of Graz

  2017cites this paper
• Factors Influencing Length of Stay in Cholecystectomy Patients in a Community Hospital

  2017cites this paper
• Enteropatía Por Olmesartán

  2017cites this paper
• A Case of Moderate Sprue-Like Enteropathy Associated With Telmisartan

  2017cites this paper
• Olmesartan-Associated Enteropathy

  2017cites this paper
• Risk of diarrhea in a long-term cohort of renal transplant patients given mycophenolate mofetil : the significant role of the UGT 1 A 8 * 2 variant allele

  2017cites this paper
• Rare Case of Olmesartan Induced Enteropathy

  2017cites this paper
• Síndrome de malabsorción

  2016cites this paper
• The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000–2015)

  2016cites this paper
• Intestinal metabolites, chronic kidney disease and renal transplantation: Enigma Variations?

  2016cites this paper
• Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases

  2016cites this paper
• Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.

  2016cites this paper
• Celiac Disease: A Disorder Emerging from Antiquity, Its Evolving Classification and Risk, and Potential New Treatment Paradigms

  2015cites this paper
• Clinical-Pathological Conference Series from the Medical University of Graz

  2015cites this paper
• [Non celiac villous atrophy: more confusion or a new syndrome?].

  2015cites this paper
• Fructooligosaccharide raftilose reduces the mycophenolate mofetil-induced complications: Hematological and biochemical alterations

  2015cites this paper
• A Review of Current Evidence of Olmesartan Medoxomil Mimicking Symptoms of Celiac Disease

  2015cites this paper
• Diagnosis and treatment Non-celiac villous atrophy : More confusion or a new syndrome ?

  2015cites this paper
• Drug-Induced Enteropathy

  2015cites this paper
• Enteropathy by olmesartan

  2015cites this paper
• Optimizing immunosuppressive therapy after renal transplantation

  2015cites this paper
• [Non celiac villous atrophy: more confusion or a new syndrome?].

  2015cites this paper
• Intestinal Biopsy in the Diagnosis of Celiac Disease: Is it still the Gold Standard?

  2015cites this paper
• [Enteropathy by olmesartan].

  2015cites this paper
• Enteropatia sensible al gluten en pacients amb malalties autoimmunes sistèmiques: Aspectes fisiopatològics i rellevància clínica

  2015cites this paper
• Pediatric Malnutrition: Putting the New Definition and Standards Into Practice.

  2015cites this paper
• The Clinical Relevance of Anti-Gliadin Antibodies in the Ageing Population

  2014cites this paper
• Olmesartan and drug-induced enteropathy.

  2014cites this paper
• Severe spruelike enteropathy due to olmesartan.

  2014influential citation
• Systematic review: sprue‐like enteropathy associated with olmesartan

  2014cites this paper
• Drug-induced Sprue-like Intestinal Disease

  2014cites this paper
• Olmesartan-related sprue-like enteropathy

  2014cites this paper
• Spruelike Enteropathy Associated with Olmesartan: An Unusual Case of Severe Diarrhea

  2013influential citation
• Villous Atrophy and Negative Celiac Serology: A Diagnostic and Therapeutic Dilemma

  2013cites this paper
• Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders

  2013cites this paper
• Histological spectrum of mycophenolate mofetil‐related colitis: association with apoptosis

  2013cites this paper
• Histologic Features in Colon Biopsies Can Discriminate Mycophenolate From GVHD-induced Colitis

  2013cites this paper
• Diarrhoea due to small bowel diseases.

  2012cites this paper
• Mycophenolate Mofetil-Related Enterocolitis and Weight Loss: A Pediatric Case Series

  2012cites this paper
• Treatment of systemic lupus erythematosus: a 2012 update.

  2012cites this paper
• Severe spruelike enteropathy associated with olmesartan.

  2012cites this paper
• Effect of Mild Diarrhea on Tacrolimus Exposure

  2012cites this paper
• Proteomic investigation of the molecular targets of mycophenolic acid in human cells

  2012cites this paper
• Duodenal Villous Atrophy: A Cause of Chronic Diarrhea After Solid‐Organ Transplantation

  2011cites this paper
• Nitric oxide and acute phase proteins are involved in pathogenesis of mycophenolate mofetil-induced gastrointestinal disorders in rats.

  2011cites this paper
• The direct and systemic influence of immunosuppressive drugs on intestinal glucose absorption, barrier function and chloride secretion in rat models

  2011influential citation
• Systemic influence of immunosuppressive drugs on small and large bowel transport and barrier function

  2011cites this paper
• The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation

  2011cites this paper
• [Duodenal villous atrophy associated with Mycophenolate mofetil: report of one case].

  2010cites this paper
• Patterns of injury in mycophenolate mofetil-related colitis.

  2010cites this paper
• Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

  2010cites this paper
• The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients

  2010cites this paper
• Mycophenolate induced diarrhoea.

  2010cites this paper
• [Duodenal villous atrophy associated with Mycophenolate mofetil: report of one case].

  2010cites this paper
• Early ileocolonoscopy with biopsy for the evaluation of persistent post-transplantation diarrhea.

  2010cites this paper
• Risk of diarrhea in a long-term cohort of renal transplant patients given mycophenolate mofetil : the significant role of the UGT 1 A 8 * 2 variant allele

  2010cites this paper
• Miscellaneous diseases of the small intestine

  2009cites this paper
• Steatorrhoea complicating post-infectious diarrhoea in a renal transplant patient on mycophenolate mofetil therapy

  2009cites this paper
• Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: was mycophenolate the cause?

  2008influential citation
• Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study

  2008cites this paper
• Clinically “silent” weight loss associated with mycophenolate mofetil in pediatric renal transplant recipients

  2008cites this paper
• Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: was mycophenolate the cause?

  2008influential citation
• Plasma Concentrations of Mycophenolic Acid Acyl Glucuronide Are Not Associated with Diarrhea in Renal Transplant Recipients

  2007cites this paper
• Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal.

  2007cites this paper
• Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients

  2007cites this paper
• Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs

  2007cites this paper
• Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road.

  2006cites this paper
• A Bayesian approach to acute infectious diarrhea in adults.

  2006cites this paper
• Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium.

  2005cites this paper
• Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability

  2005cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2005cites this paper